Align Technology, Inc. (ALGN)
USD 152.83
(-0.91%)
USD 152.83
(-0.91%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.08 Billion USD | 2.29% |
| 2022 | 5.94 Billion USD | 0.1% |
| 2021 | 5.94 Billion USD | 23.03% |
| 2020 | 4.82 Billion USD | 93.13% |
| 2019 | 2.5 Billion USD | 21.84% |
| 2018 | 2.05 Billion USD | 15.45% |
| 2017 | 1.77 Billion USD | 27.34% |
| 2016 | 1.39 Billion USD | 20.5% |
| 2015 | 1.15 Billion USD | 17.27% |
| 2014 | 987.99 Million USD | 18.73% |
| 2013 | 832.14 Million USD | 10.03% |
| 2012 | 756.31 Million USD | 16.49% |
| 2011 | 649.26 Million USD | 36.13% |
| 2010 | 476.94 Million USD | 34.26% |
| 2009 | 355.24 Million USD | 27.17% |
| 2008 | 279.34 Million USD | 25.4% |
| 2007 | 222.76 Million USD | 46.98% |
| 2006 | 151.55 Million USD | 6.65% |
| 2005 | 142.11 Million USD | 8.72% |
| 2004 | 130.71 Million USD | 27.9% |
| 2003 | 102.2 Million USD | 10.07% |
| 2002 | 92.85 Million USD | -21.45% |
| 2001 | 118.21 Million USD | 67.54% |
| 2000 | 70.56 Million USD | 312.85% |
| 1999 | 17.09 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.15 Billion USD | 0.04% |
| 2024 Q3 | 6.36 Billion USD | 3.37% |
| 2024 Q1 | 6.15 Billion USD | 1.18% |
| 2023 Q1 | 5.9 Billion USD | -0.78% |
| 2023 FY | 6.08 Billion USD | 2.29% |
| 2023 Q4 | 6.08 Billion USD | -3.71% |
| 2023 Q2 | 6.14 Billion USD | 4.12% |
| 2023 Q3 | 6.31 Billion USD | 2.83% |
| 2022 Q3 | 5.91 Billion USD | 1.77% |
| 2022 Q4 | 5.94 Billion USD | 0.59% |
| 2022 FY | 5.94 Billion USD | 0.1% |
| 2022 Q1 | 5.94 Billion USD | 0.02% |
| 2022 Q2 | 5.81 Billion USD | -2.24% |
| 2021 Q3 | 5.65 Billion USD | 4.72% |
| 2021 Q4 | 5.94 Billion USD | 5.17% |
| 2021 FY | 5.94 Billion USD | 23.03% |
| 2021 Q2 | 5.39 Billion USD | 6.43% |
| 2021 Q1 | 5.06 Billion USD | 4.97% |
| 2020 Q4 | 4.82 Billion USD | 9.39% |
| 2020 FY | 4.82 Billion USD | 93.13% |
| 2020 Q1 | 3.96 Billion USD | 58.55% |
| 2020 Q2 | 4.02 Billion USD | 1.54% |
| 2020 Q3 | 4.41 Billion USD | 9.67% |
| 2019 Q1 | 2.23 Billion USD | 8.87% |
| 2019 FY | 2.5 Billion USD | 21.84% |
| 2019 Q4 | 2.5 Billion USD | 6.4% |
| 2019 Q3 | 2.35 Billion USD | 0.19% |
| 2019 Q2 | 2.34 Billion USD | 4.99% |
| 2018 Q3 | 1.92 Billion USD | 0.62% |
| 2018 FY | 2.05 Billion USD | 15.45% |
| 2018 Q2 | 1.91 Billion USD | 7.51% |
| 2018 Q1 | 1.78 Billion USD | 0.27% |
| 2018 Q4 | 2.05 Billion USD | 6.43% |
| 2017 Q1 | 1.45 Billion USD | 4.52% |
| 2017 Q2 | 1.55 Billion USD | 6.3% |
| 2017 Q4 | 1.77 Billion USD | 4.73% |
| 2017 Q3 | 1.69 Billion USD | 9.44% |
| 2017 FY | 1.77 Billion USD | 27.34% |
| 2016 Q3 | 1.35 Billion USD | 8.6% |
| 2016 FY | 1.39 Billion USD | 20.5% |
| 2016 Q2 | 1.25 Billion USD | 3.62% |
| 2016 Q4 | 1.39 Billion USD | 2.74% |
| 2016 Q1 | 1.2 Billion USD | 4.22% |
| 2015 FY | 1.15 Billion USD | 17.27% |
| 2015 Q1 | 1.02 Billion USD | 4.09% |
| 2015 Q2 | 1.02 Billion USD | 0.02% |
| 2015 Q3 | 1.07 Billion USD | 4.96% |
| 2015 Q4 | 1.15 Billion USD | 7.32% |
| 2014 Q2 | 885.43 Million USD | -0.02% |
| 2014 Q3 | 948.28 Million USD | 7.1% |
| 2014 Q4 | 987.99 Million USD | 4.19% |
| 2014 FY | 987.99 Million USD | 18.73% |
| 2014 Q1 | 885.64 Million USD | 6.43% |
| 2013 Q2 | 703.89 Million USD | -3.08% |
| 2013 Q3 | 759.2 Million USD | 7.86% |
| 2013 Q4 | 832.14 Million USD | 9.61% |
| 2013 FY | 832.14 Million USD | 10.03% |
| 2013 Q1 | 726.24 Million USD | -3.98% |
| 2012 Q2 | 744.16 Million USD | 11.0% |
| 2012 Q1 | 670.43 Million USD | 3.26% |
| 2012 Q4 | 756.31 Million USD | -4.61% |
| 2012 FY | 756.31 Million USD | 16.49% |
| 2012 Q3 | 792.82 Million USD | 6.54% |
| 2011 Q2 | 547.04 Million USD | 10.07% |
| 2011 FY | 649.26 Million USD | 36.13% |
| 2011 Q3 | 585.92 Million USD | 7.11% |
| 2011 Q4 | 649.26 Million USD | 10.81% |
| 2011 Q1 | 496.98 Million USD | 4.2% |
| 2010 FY | 476.94 Million USD | 34.26% |
| 2010 Q4 | 476.94 Million USD | 7.12% |
| 2010 Q1 | 373.55 Million USD | 5.15% |
| 2010 Q3 | 445.23 Million USD | 8.94% |
| 2010 Q2 | 408.69 Million USD | 9.41% |
| 2009 Q3 | 330.78 Million USD | 7.47% |
| 2009 Q2 | 307.79 Million USD | 6.4% |
| 2009 Q1 | 289.27 Million USD | 3.56% |
| 2009 FY | 355.24 Million USD | 27.17% |
| 2009 Q4 | 355.24 Million USD | 7.39% |
| 2008 Q1 | 231.05 Million USD | 3.72% |
| 2008 Q3 | 216.52 Million USD | -0.3% |
| 2008 Q2 | 217.16 Million USD | -6.01% |
| 2008 FY | 279.34 Million USD | 25.4% |
| 2008 Q4 | 279.34 Million USD | 29.01% |
| 2007 Q3 | 206.89 Million USD | 13.46% |
| 2007 Q4 | 222.76 Million USD | 7.67% |
| 2007 Q1 | 157.03 Million USD | 3.62% |
| 2007 Q2 | 182.35 Million USD | 16.12% |
| 2007 FY | 222.76 Million USD | 46.98% |
| 2006 Q1 | 144.98 Million USD | 2.03% |
| 2006 Q3 | 156.89 Million USD | 10.68% |
| 2006 Q2 | 141.75 Million USD | -2.23% |
| 2006 Q4 | 151.55 Million USD | -3.4% |
| 2006 FY | 151.55 Million USD | 6.65% |
| 2005 Q4 | 142.11 Million USD | -2.0% |
| 2005 FY | 142.11 Million USD | 8.72% |
| 2005 Q1 | 136.67 Million USD | 4.56% |
| 2005 Q2 | 145.23 Million USD | 6.27% |
| 2005 Q3 | 145.01 Million USD | -0.15% |
| 2004 FY | 130.71 Million USD | 27.9% |
| 2004 Q1 | 103.7 Million USD | 1.47% |
| 2004 Q2 | 114.95 Million USD | 10.85% |
| 2004 Q3 | 125.18 Million USD | 8.9% |
| 2004 Q4 | 130.71 Million USD | 4.42% |
| 2003 Q4 | 102.2 Million USD | 6.63% |
| 2003 Q1 | 89.66 Million USD | -3.44% |
| 2003 Q2 | 91.79 Million USD | 2.38% |
| 2003 Q3 | 95.85 Million USD | 4.42% |
| 2003 FY | 102.2 Million USD | 10.07% |
| 2002 Q1 | 104.32 Million USD | -11.75% |
| 2002 Q4 | 92.85 Million USD | 18.15% |
| 2002 Q3 | 78.58 Million USD | -14.53% |
| 2002 Q2 | 91.94 Million USD | -11.87% |
| 2002 FY | 92.85 Million USD | -21.45% |
| 2001 Q2 | 148.21 Million USD | -13.6% |
| 2001 Q3 | 130.73 Million USD | -11.79% |
| 2001 Q4 | 118.21 Million USD | -9.58% |
| 2001 FY | 118.21 Million USD | 67.54% |
| 2001 Q1 | 171.55 Million USD | 0.0% |
| 2000 FY | 70.56 Million USD | 312.85% |
| 1999 FY | 17.09 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -19296.407% |
| BrainsWay Ltd. | 62.97 Million USD | -9561.242% |
| Cerus Corporation | 197.74 Million USD | -2976.581% |
| Envoy Medical, Inc. | 7.64 Million USD | -79531.898% |
| electroCore, Inc. | 16.38 Million USD | -37026.24% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -78993.565% |
| IceCure Medical Ltd | 16.41 Million USD | -36974.205% |
| Inogen, Inc. | 326.19 Million USD | -1765.11% |
| OrthoPediatrics Corp. | 449.58 Million USD | -1253.218% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -22209.78% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -36596.265% |
| MaxCyte, Inc. | 268.27 Million USD | -2167.785% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -75034.508% |
| Nexalin Technology, Inc. | 3.63 Million USD | -167411.501% |
| Orthofix Medical Inc. | 925.31 Million USD | -557.493% |
| PAVmed Inc | 33.11 Million USD | -18269.748% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -4141.054% |
| RxSight, Inc. | 182.55 Million USD | -3232.718% |
| Sight Sciences, Inc. | 166.65 Million USD | -3550.669% |
| SI-BONE, Inc. | 230.42 Million USD | -2540.285% |
| TELA Bio, Inc. | 78.04 Million USD | -7695.045% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -2315.128% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -56599.692% |
| Acutus Medical, Inc. | 53.96 Million USD | -11174.791% |
| Talis Biomedical Corporation | 98.34 Million USD | -6086.574% |
| Spectral AI, Inc. | 10.69 Million USD | -56801.207% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -2682.498% |
| CVRx, Inc. | 115.22 Million USD | -5179.814% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -10271.248% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -195193.191% |
| Bioventus Inc. | 810.91 Million USD | -650.253% |
| Venus Concept Inc. | 93.65 Million USD | -6396.121% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -23549.668% |
| LivaNova PLC | 2.42 Billion USD | -150.41% |
| 908 Devices Inc. | 202.98 Million USD | -2897.264% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -655.566% |
| Nemaura Medical Inc. | 14.56 Million USD | -41675.593% |
| NeuroPace, Inc. | 107.65 Million USD | -5551.482% |
| LENSAR, Inc. | 69.58 Million USD | -8643.087% |
| Apyx Medical Corporation | 79.24 Million USD | -7577.785% |
| Cutera, Inc. | 346.29 Million USD | -1656.868% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -14379.905% |
| BioSig Technologies, Inc. | 1.79 Million USD | -338269.132% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -2148.026% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -14160.981% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | -60.865% |
| Axonics, Inc. | 719.92 Million USD | -745.073% |
| Outset Medical, Inc. | 313.8 Million USD | -1838.769% |
| IRIDEX Corporation | 34.43 Million USD | -17567.2% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -1403.242% |
| IRadimed Corporation | 92.15 Million USD | -6501.709% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -115695.147% |
| INVO Bioscience, Inc. | 20.88 Million USD | -29026.48% |
| Telesis Bio, Inc. | 70.41 Million USD | -8540.521% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -3847.942% |
| Varex Imaging Corporation | 1.24 Billion USD | -386.866% |
| Quipt Home Medical Corp. | 247.4 Million USD | -2359.046% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -65247.766% |
| Pulmonx Corporation | 178.95 Million USD | -3299.745% |
| Dynatronics Corporation | 25.94 Million USD | -23353.145% |
| Modular Medical, Inc. | 13.8 Million USD | -43963.714% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -56615.55% |
| Semler Scientific, Inc. | 78.06 Million USD | -7693.348% |
| InMode Ltd. | 863.28 Million USD | -604.735% |
| Bruker Corporation | 4.24 Billion USD | -43.153% |
| Cytosorbents Corporation | 53.26 Million USD | -11322.84% |
| DexCom, Inc. | 6.26 Billion USD | 2.883% |
| Viveve Medical, Inc. | 25.91 Million USD | -23378.088% |
| ZimVie Inc. | 1.2 Billion USD | -404.742% |
| Movano Inc. | 9.42 Million USD | -64477.826% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -1122.475% |
| Nexalin Technology, Inc. | 3.63 Million USD | -167411.501% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -10271.248% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -538.621% |
| Profound Medical Corp. | 43.68 Million USD | -13826.269% |
| Insulet Corporation | 2.58 Billion USD | -135.062% |
| enVVeno Medical Corporation | 48.63 Million USD | -12409.257% |
| Surmodics, Inc. | 185.73 Million USD | -3175.604% |
| iCAD, Inc. | 41.41 Million USD | -14588.969% |
| Nuwellis, Inc. | 9.77 Million USD | -62171.003% |
| Biotricity, Inc. | 5.94 Million USD | -102276.929% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -1304.585% |
| Aethlon Medical, Inc. | 8.24 Million USD | -73679.897% |
| InspireMD, Inc. | 47.64 Million USD | -12669.719% |
| PAVmed Inc. | 33.11 Million USD | -18269.748% |
| BIOLASE, Inc. | 35.1 Million USD | -17232.489% |
| Beyond Air, Inc. | 56.96 Million USD | -10580.776% |
| FONAR Corporation | 214.24 Million USD | -2739.669% |
| AxoGen, Inc. | 196.82 Million USD | -2990.977% |
| Vivani Medical, Inc. | 45.79 Million USD | -13184.444% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -2061.711% |
| Inari Medical, Inc. | 674.23 Million USD | -802.338% |
| UFP Technologies, Inc. | 404.13 Million USD | -1405.403% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -25901.072% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -63919.832% |
| Tenon Medical, Inc. | 6.34 Million USD | -95784.586% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -64573.934% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -5769.764% |
| AdaptHealth Corp. | 4.61 Billion USD | -31.691% |
| Sintx Technologies, Inc. | 15.36 Million USD | -39495.685% |
| NanoVibronix, Inc. | 6.67 Million USD | -91057.881% |
| Quanterix Corporation | 425.01 Million USD | -1331.463% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -65247.766% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -11223.686% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | -248.444% |
| TransMedics Group, Inc. | 706.04 Million USD | -761.682% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -9527.606% |
| NeuroMetrix, Inc. | 21.42 Million USD | -28296.9% |
| Hyperfine, Inc. | 94.19 Million USD | -6358.537% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -2164.687% |
| Biomerica, Inc. | 9.25 Million USD | -65643.214% |
| Bone Biologics Corporation | 3.73 Million USD | -162667.864% |
| AVITA Medical, Inc. | 144.33 Million USD | -4114.963% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -124863.3% |
| Silk Road Medical, Inc | 265.3 Million USD | -2193.129% |